The distinct role of CD4+ and CD8+ T-cells during the anti-tumour effects of targeted superantigens
1999
The Role of T-Cells in Tumor Therapy
publication
Evidence: moderate
Author Information
Author(s): Litton M J, Dohlsten M, Rosendahl A, Ohlsson L, Søgaard M, Andersson J, Andersson U
Primary Institution: Department of Immunology, Wenner-Gren's Institute, Stockholm University
Hypothesis
What is the distinct role of CD4+ and CD8+ T-cells during the anti-tumour effects of targeted superantigens?
Conclusion
The study found that both CD4+ and CD8+ T-cells play crucial roles in the effectiveness of targeted superantigen therapy against tumors.
Supporting Evidence
- Therapy was shown to eliminate over 95% of pulmonary metastasis in mice with melanoma.
- CD4 KO mice had a drastic reduction in tumor-infiltrating macrophages and CD8+ T-cells.
- CD8 KO mice produced interleukin-4 and interleukin-10, which inhibited therapy effectiveness.
Takeaway
Scientists studied how two types of immune cells help fight tumors, finding that both are important for the treatment to work well.
Methodology
The study used CD4 and CD8 knockout mice to analyze therapeutic effects of a recombinant protein targeting T-cells.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website